Abstracts tagged "tenosynovitis and age"

Abstract Number: 2751 • 2019 ACR/ARP Annual Meeting
Very Low Prevalence of Ultrasound Determined Tendon Abnormalities in Healthy Subjects Throughout the Age Range: An Outcome Measures in Rheumatology (OMERACT) Ultrasound Minimal Disease Study
Jeanette Trickey¹, Ilfita Sahbudin ², Alessandra Bortoluzzi ³, ANNAMARIA IAGNOCCO ⁴, Carlos Pineda ⁵, Cesar Sifuentes-Cantú ⁶, Coziana Ciurtin ⁷, Cristina Reátegui-Sokolova ⁸, Daniela Fodor ⁹, ESPERANZA NAREDO ¹⁰, Ellen-Margrethe Hauge ¹¹, Florentin Vreju ¹², Garifallia Sakellariou ¹³, George A. W. Bruyn ¹⁴, Georgios Filippou ¹⁵, Giuliana La Paglia ⁶, Gustavo Leon ¹⁶, Hélène Gouze ¹⁷, Helen Keen ¹⁸, Hilde Hammer ¹⁹, Ilaria Tinazzi ²⁰, Irene Azzolin ⁴, Jacek Fliciński ²¹, Kei Ikeda ²², Lene Terslev ²³, Mads Ammitzball Danielsen ²⁴, Mads Nyhuus Bendix Rasch ¹¹, Marcin Milchert ²¹, Maria Stoenoiu ²⁵, Marion Kortekaas ²⁶, Marwin Gutierrez ⁵, Mihaela Maruseac ²⁷, Mohamed Mortada ²⁸, Philippe Carron ²⁹, Rositsa Karalilova ³⁰, Ruth Wittoek ³¹, Sarah Ohrndorf ³², Takeshi Suzuki ³³, Teodora Șerban ³⁴, Maria-Antonietta D’Agostino ³⁵ and Andrew Filer ³⁶, ¹Institute of Inflammation and Ageing, University of Birmingham, Hereford, United Kingdom, ²Institute of Inflammation and Ageing, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom, ³University of Ferrara, Ferrara, Italy, ⁴Academic Rheumatology Centre, Università degli Studi di Torino, TURIN, Italy, ⁵Division of Musculoskeletal and Rheumatic Diseases, Instituto Nacional de Rehabilitación “Luis Guillermo Ibarra Ibarra”, Mexico, Mexico, Mexico, ⁶Department of Rheumatology, Bone and Joint Research Unit. Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain, ⁷Centre for Adolescent Rheumatology, University College London London, UK, Londond, United Kingdom, ⁸Hospital Guillermo Almenara Irigoyen. EsSalud, Lima, Peru, ⁹2nd Internal Medicine Department, "Iuliu Hatieganu" University of Medicine and Pharmacy, Cluj-Napoca, Cluj-Napoca, Romania, ¹⁰Rheumatology Department, Joint and Bone Research Unit. Hospital Universitario Fundación Jiménez Díaz, Universidad Autónoma, MADRID, Spain, ¹¹Department of Rheumatology, Aarhus University Hospital, Aarhus, Denmark, ¹²Department of Rheumatology, University of Medicine and Pharmacy Craiova, Craiova, Romania, ¹³Division of Rheumatology, University of Pavia, IRCCS Policlinico San Matteo Foundation, Pavia, Italy, ¹⁴Department of Rheumatology, MC Groep Hospitals., Lelystad, Netherlands, ¹⁵University of Ferrara, Cona, Italy, ¹⁶Instituto Nacional de Rehabilitacion, Mexico City, Lima, Peru, ¹⁷Rheumatology Department, APHP, Ambroise Paré Hospital, Bolougne Billancourt, France, ¹⁸School of Medicine and Pharmacology Fiona Stanley Hospital Unit, University of Western Australia, Perth, Australia, ¹⁹Diakonhjemmet Hospital, Oslo, Norway, ²⁰Sacro Cuore Don Calabria Hospital, Unit of Rheumatology, Verona, Italy, ²¹Department of Rheumatology, Internal Diseases and Geriatrics; Pomeranian Medical University, Szczecin, Poland, ²²Chiba University Hospital, Chiba, Japan, ²³Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet, Glostrup, Copenhagen, Denmark, ²⁴Copenhagen University Hospital, Copenhagen, Denmark, ²⁵Cliniques universitaires Saint-Luc - Université Catholique de Louvain - Institut de Recherche Expérimentale et Clinique, Bruxelles, Belgium, ²⁶Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands, ²⁷Department of Rheumatology, Cliniques Universitaires Saint-Luc, Institut de recherche expérimentale et clinique (IREC), Université catholique de Louvain, Brussels, Belgium, ²⁸Rheumatology and Rehabilitation Department, Faculty of Medicine, Zagazig University, Egypt, Zagazig, Egypt, ²⁹Ghent University Hospital, Ghent, Belgium, ³⁰Clinic of Rheumatology, Medical University of Plovdiv, University Hospital “Kaspela", Plovdiv, Bulgaria, ³¹Ghent University Hospital, Gent University, Gent, Belgium, ³²Charité Universitätsmedizin Berlin, Berlin, Germany, ³³Division of Allergy and Rheumatology, Japanese Red Cross Medical Center, Tokyo, Japan, ³⁴SC Reumatologia, Ospedale La Colletta, Genoa, Italy, ³⁵Department of Rheumatology, APHP, Hôpital Ambroise Paré, Paris, France, ³⁶Institute of Inflammation and Ageing College of Medical and Dental Sciences University of Birmingham, Birmingham, United Kingdom
Background/Purpose: Tenosynovitis (TS) is a common, often clinically undetectable finding in Rheumatoid Arthritis (RA). Recent data showed TS on ultrasound (US) has a role in…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].